# Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis

> **NCT07149753** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Universidad Industrial de Santander** · enrollment: 15 (estimated)

## Conditions studied

- Cutaneous Leishmaniasis
- Cutaneous Leishmaniasis, American
- Topical Administration

## Interventions

- **DRUG:** MILTEFOSINE gel

## Key facts

- **NCT ID:** NCT07149753
- **Lead sponsor:** Universidad Industrial de Santander
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-07-20
- **Final completion:** 2026-08-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07149753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07149753, "Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07149753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*